Quantitative phosphoproteomics of CXCL12 (SDF-1) signaling.
CXCL12 (SDF-1) is a chemokine that binds to and signals through the seven transmembrane receptor CXCR4. The CXCL12/CXCR4 signaling axis has been implicated in both cancer metastases and human immunodeficiency virus type 1 (HIV-1) infection and a more complete understanding of CXCL12/CXCR4 signaling...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2011-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC3176801?pdf=render |
| _version_ | 1818947908553146368 |
|---|---|
| author | Jason A Wojcechowskyj Jessica Y Lee Steven H Seeholzer Robert W Doms |
| author_facet | Jason A Wojcechowskyj Jessica Y Lee Steven H Seeholzer Robert W Doms |
| author_sort | Jason A Wojcechowskyj |
| collection | DOAJ |
| description | CXCL12 (SDF-1) is a chemokine that binds to and signals through the seven transmembrane receptor CXCR4. The CXCL12/CXCR4 signaling axis has been implicated in both cancer metastases and human immunodeficiency virus type 1 (HIV-1) infection and a more complete understanding of CXCL12/CXCR4 signaling pathways may support efforts to develop therapeutics for these diseases. Mass spectrometry-based phosphoproteomics has emerged as an important tool in studying signaling networks in an unbiased fashion. We employed stable isotope labeling with amino acids in cell culture (SILAC) quantitative phosphoproteomics to examine the CXCL12/CXCR4 signaling axis in the human lymphoblastic CEM cell line. We quantified 4,074 unique SILAC pairs from 1,673 proteins and 89 phosphopeptides were deemed CXCL12-responsive in biological replicates. Several well established CXCL12-responsive phosphosites such as AKT (pS473) and ERK2 (pY204) were confirmed in our study. We also validated two novel CXCL12-responsive phosphosites, stathmin (pS16) and AKT1S1 (pT246) by Western blot. Pathway analysis and comparisons with other phosphoproteomic datasets revealed that genes from CXCL12-responsive phosphosites are enriched for cellular pathways such as T cell activation, epidermal growth factor and mammalian target of rapamycin (mTOR) signaling, pathways which have previously been linked to CXCL12/CXCR4 signaling. Several of the novel CXCL12-responsive phosphoproteins from our study have also been implicated with cellular migration and HIV-1 infection, thus providing an attractive list of potential targets for the development of cancer metastasis and HIV-1 therapeutics and for furthering our understanding of chemokine signaling regulation by reversible phosphorylation. |
| first_indexed | 2024-12-20T08:38:23Z |
| format | Article |
| id | doaj.art-f6cd821be8e342fdabe0a17e90cb3cc8 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-20T08:38:23Z |
| publishDate | 2011-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-f6cd821be8e342fdabe0a17e90cb3cc82022-12-21T19:46:29ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-0169e2491810.1371/journal.pone.0024918Quantitative phosphoproteomics of CXCL12 (SDF-1) signaling.Jason A WojcechowskyjJessica Y LeeSteven H SeeholzerRobert W DomsCXCL12 (SDF-1) is a chemokine that binds to and signals through the seven transmembrane receptor CXCR4. The CXCL12/CXCR4 signaling axis has been implicated in both cancer metastases and human immunodeficiency virus type 1 (HIV-1) infection and a more complete understanding of CXCL12/CXCR4 signaling pathways may support efforts to develop therapeutics for these diseases. Mass spectrometry-based phosphoproteomics has emerged as an important tool in studying signaling networks in an unbiased fashion. We employed stable isotope labeling with amino acids in cell culture (SILAC) quantitative phosphoproteomics to examine the CXCL12/CXCR4 signaling axis in the human lymphoblastic CEM cell line. We quantified 4,074 unique SILAC pairs from 1,673 proteins and 89 phosphopeptides were deemed CXCL12-responsive in biological replicates. Several well established CXCL12-responsive phosphosites such as AKT (pS473) and ERK2 (pY204) were confirmed in our study. We also validated two novel CXCL12-responsive phosphosites, stathmin (pS16) and AKT1S1 (pT246) by Western blot. Pathway analysis and comparisons with other phosphoproteomic datasets revealed that genes from CXCL12-responsive phosphosites are enriched for cellular pathways such as T cell activation, epidermal growth factor and mammalian target of rapamycin (mTOR) signaling, pathways which have previously been linked to CXCL12/CXCR4 signaling. Several of the novel CXCL12-responsive phosphoproteins from our study have also been implicated with cellular migration and HIV-1 infection, thus providing an attractive list of potential targets for the development of cancer metastasis and HIV-1 therapeutics and for furthering our understanding of chemokine signaling regulation by reversible phosphorylation.http://europepmc.org/articles/PMC3176801?pdf=render |
| spellingShingle | Jason A Wojcechowskyj Jessica Y Lee Steven H Seeholzer Robert W Doms Quantitative phosphoproteomics of CXCL12 (SDF-1) signaling. PLoS ONE |
| title | Quantitative phosphoproteomics of CXCL12 (SDF-1) signaling. |
| title_full | Quantitative phosphoproteomics of CXCL12 (SDF-1) signaling. |
| title_fullStr | Quantitative phosphoproteomics of CXCL12 (SDF-1) signaling. |
| title_full_unstemmed | Quantitative phosphoproteomics of CXCL12 (SDF-1) signaling. |
| title_short | Quantitative phosphoproteomics of CXCL12 (SDF-1) signaling. |
| title_sort | quantitative phosphoproteomics of cxcl12 sdf 1 signaling |
| url | http://europepmc.org/articles/PMC3176801?pdf=render |
| work_keys_str_mv | AT jasonawojcechowskyj quantitativephosphoproteomicsofcxcl12sdf1signaling AT jessicaylee quantitativephosphoproteomicsofcxcl12sdf1signaling AT stevenhseeholzer quantitativephosphoproteomicsofcxcl12sdf1signaling AT robertwdoms quantitativephosphoproteomicsofcxcl12sdf1signaling |